Saturday, May 30, 2026
CN
  • About
  • Advertise
  • Careers
  • Contact
Money Compass
  • Home
  • Financial News
  • Investment News
  • Other News
    • Bursa News
    • Government News
    • Listing Companies News
    • Oversea Financial & Investment News
  • Interviews
    • Features Interviews
    • Corporate Interviews
  • Financial & Investment Articles
  • PR Newswire
  • Login
No Result
View All Result
Money Compass
Home PR Newswire

EngineAI Launches Shenzhen Intelligent Manufacturing Base as First Batch of T800 Humanoid Robots Roll Off the Production Line to Begin Mass Delivery

Money Compass by Money Compass
May 29, 2026
in PR Newswire
0
EngineAI Launches Shenzhen Intelligent Manufacturing Base as First Batch of T800 Humanoid Robots Roll Off the Production Line to Begin Mass Delivery
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

SHENZHEN, China, May 29, 2026 /PRNewswire/ — EngineAI Robotics, an innovator in humanoid robots, announced the official launch of EngineAI Intelligent Manufacturing (Honghualing, Shenzhen) Base, alongside the rollout of the first batch of its flagship T800 full-size humanoid robots. This milestone marks the company’s decisive entry into a new phase of 10,000-unit scalable delivery capability.


(PRNewsfoto/EngineAI)

Spanning around 12,000 square meters, the Shenzhen Base features an integrated, closed-loop manufacturing process that covers everything from incoming material inspection and component assembly testing to final assembly, end-of-line testing, mass shipment, and after-sales maintenance. With this efficient layout, a new humanoid robot can roll off the production line every 15 minutes.

Related posts

The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet

The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet

May 30, 2026
Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO

Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO

May 30, 2026

“From our first test machine in 2024, to the small-scale production of hundreds of PM01 units in 2025, and now to the qualitative leap toward a 10,000-unit delivery capability, we are entering a new phase of industrialization and commercialization,” said Mr. Zhao Tongyang, Founder and CEO of EngineAI. “By building a manufacturing system centered on quality, efficiency, and intelligent production, we have accelerated our journey from pilot production to mass manufacturing and from zero to scale.”

Four Strategic Pillars for Uncompromising Quality

Leveraging its full-stack independent R&D capability, EngineAI has established a rigorous quality assurance framework built upon four strategic pillars:

  • Supply Chain Quality Control: All components, from integrated joints to full assemblies, meet strict standards to ensure only qualified parts enter the production flow.
  • Advanced Production Processes: Automated locking, gluing, and laser welding equipment has increased production efficiency by 40% while maintaining strict process standardization.
  • Smart Manufacturing Upgrade: A comprehensive digital management system enables full-link traceability, giving every component and finished robot a unique production identity trackable across the entire value chain.
  • Rigorous Testing & Validation: Each robot must pass 79 full-dimensional quality inspections and 46 working condition simulation tests before delivery, ensuring consistent high performance and stability across every unit.

Multi-Regional Capacity Layout to Support Global Expansion

“As our intelligent manufacturing network expands across Shenzhen, Henan, and beyond, these facilities will work together to better allocate capacity and respond faster to the market, creating a more efficient foundation for future global growth,” said Mr. Ren Guowen, Co-founder of EngineAI.

About EngineAI

Founded in October 2023, EngineAI is an innovator in the field of general-purpose embodied intelligence. Its core team consists of industry professionals from leading global universities, combining strong academic expertise with extensive engineering experience. The company has achieved full-stack in-house development across core robotic components, motion control algorithms, and embodied AI technologies. Its product portfolio spans multiple application scenarios, including the SA01, designed to make advanced robotics more accessible; the SE01, which demonstrated one of the world’s earliest human-like walking capabilities; the PM01, which achieved the world’s first humanoid robot front flip; and the T800, designed for high-dynamic and heavy-duty operational environments.

As humanoid robotics moves from research to real-world deployment, EngineAI is working with partners across commercial services, education, scientific research, and industrial manufacturing to accelerate large-scale adoption. The company is committed to advancing embodied intelligence through continuous innovation and delivering practical robotic solutions that help shape the future of work and industry.

For more information about EngineAI, please visit https://en.engineai.com.cn/

Ins: engineairobot
Facebook: Engine Ai
X: EngineAI
YouTube: Engineai Robot
Linkedin: EngineAI


(PRNewsfoto/EngineAI)


(PRNewsfoto/EngineAI)

 

SOURCE EngineAI

​ 

Previous Post

Zero Distortion, True 1000FPS: Evnia and BOE Debut the World’s First Native 1000Hz 1080p Gaming Monitor

Next Post

Coda Receives Major Payment Institution Licence from the Monetary Authority of Singapore

Next Post
Coda Receives Major Payment Institution Licence from the Monetary Authority of Singapore

Coda Receives Major Payment Institution Licence from the Monetary Authority of Singapore

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

BROWSE BY CATEGORIES

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire

BROWSE BY TOPICS

2018 League Balinese Culture Bali United Budget Travel business Champions League Chopper Bike Doctor Terawan industrial Istana Negara Malaysia Market Stories National Exam net zero emissions targets 2025 Renewable energy Visit Bali

Recent News

  • The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet
  • Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO
  • Duke-NUS graduates biggest class yet, with new doctors drawn from business, engineering and the humanities

Category

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire
  • About
  • Advertise
  • Careers
  • Contact

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Features Interviews
  • Government News
  • Financial News
  • Investment News
  • Listing Companies News
  • Corporate Interviews
  • Bursa News
  • Financial & Investment Articles
  • Oversea Financial & Investment News

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved